Monica Bisbocci
IRBM Science Park · 20 works · 470 citations · h-index 10
Top works
- Mechanismof Action and Antiviral Activity of Benzimidazole-Based AllostericInhibitors of the Hepatitis C Virus RNA-Dependent RNAPolymerase
- Characterization of the Inhibition of Hepatitis C Virus RNA Replication by Nonnucleosides
- Discovery of a Novel Series of Imidazopyrazine Derivatives as Potent SHP2 Allosteric Inhibitors
- Vitamin B12 ameliorates the phenotype of a mouse model of DiGeorge syndrome
- Discovery of a Novel Series of Potent SHP2 Allosteric Inhibitors
- Analysis of mutant and total huntingtin expression in Huntington’s disease murine models
- Discovery and SAR of novel, potent and selective hexahydrobenzonaphthyridinone inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
- A cellular screening platform, stably expressing DENV2 NS5, defines a novel anti-DENV mechanism of action of Apigenin based on STAT2 activation
- Gametocyte-specific and all-blood-stage transmission-blocking chemotypes discovered from high throughput screening on Plasmodium falciparum gametocytes
- Vitamin B12 ameliorates the phenotype of a mouse model of DiGeorge syndrome
- Direct-to-biology platform: From synthesis to biological evaluation of SHP2 allosteric inhibitors
- An allosteric inhibitor of the Zika virus NS2B-NS3 protease with oral efficacy in mouse models
- Novel azabicyclic series of potent SHP2 allosteric inhibitors
- Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of γ-globin and β-globin gene promoters
- Abstract 1975: Discovery of I-1000233, a potent, selective and brain permeable SHP2 allosteric inhibitor
- Discovery and Optimization of IRBM-Z-2, an Allosteric Zika Virus NS2B-NS3 Protease Inhibitor Exhibiting In Vivo Efficacy
- Discovery and Preclinical Characterization of I-0436650, a Selective SHP2 Allosteric Inhibitor for RAS-Driven Cancers
- Discovery of I-0436650, a potent and selective SHP2 allosteric inhibitor for the treatment of RAS driven solid tumors
- Development and characterization of cellular biosensors for HTS of erythroid differentiation inducers targeting the transcriptional activity of gamma-globin and beta-globin gene promoters